From the MDS Beacon...
Stem Cell Transplantation In Elderly MDS Patients: The Role Of Treatment-Related Factors
by Jessica Langholtz and Maike Haehle
Dr. Nikolaus Kroeger, a German myelodysplastic syndromes expert, recently published a review of previous research to assess whether stem cell transplantation is feasible in elderly patients with myelodysplastic syndromes. He came to the conclusion that the procedure is safe and has curative potential for this patient population.
Donor stem cell transplantation is currently the only treatment available that may cure patients with myelodysplastic syndromes (MDS). In this procedure, MDS patients receive stem cells from a healthy donor to replenish their own stem cells, which are destroyed prior the transplant using high-dose chemotherapy.
For the rest, see the article at MDS Beacon.